EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Engineered bacteria for augmented in situ tumor vaccination

Xinyuan Shen, Chaojie Zhu, Xutao Liu, Hanqi Zheng, Qing Wu, Jijin Xie, Hao Huang, Ziyan Liao, Jiaqi Shi, Kewang Nan, Junxia Wang, Xuming Mao und 2 weitere

Biomaterials Science · 2023

DOI: 10.1039/d2bm01593e ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomaterials Science, 2023. Verfasst von Xinyuan Shen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Advanced Drug Delivery Systems of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Chin…. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Cancer Vaccines. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Zhejiang University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Engineered bacteria can be leveraged for in situ tumor vaccinations with their tumor-targeting ability and adjuvanticity. Engineering strategies like chemical modification, nanotechnology, and genetic engineering improve their safety and efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsCancer VaccinesHumansAntigens, NeoplasmVaccinationTumor MicroenvironmentImmunotherapy

Substanzen

Antigens, NeoplasmAntineoplastic AgentsCancer Vaccines

Autor:innen und Institutionen

  • Key Laboratory of Advanced Drug Delivery Systems of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. guzhen@zju.edu.cn.
  • Department of Hepatobiliary and Pancreatic Surgery the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China.
  • Department of Bioengineering, University of California, Los Angeles, California 90095, USA.
  • Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou 311121, China.
  • Institute of Pharmaceutical Biotechnology, School of Medicine, Zhejiang University, Hangzhou 310058, China.
  • College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310027, China.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Zhejiang University

Zitieren

APA

Shen, X., Zhu, C., Liu, X., Zheng, H., Wu, Q., Xie, J., Huang, H., Liao, Z., Shi, J., Nan, K., Wang, J., Mao, X., Gu, Z., & Li, H. (2023). Engineered bacteria for augmented in situ tumor vaccination. Biomaterials Science. https://doi.org/10.1039/d2bm01593e

Vancouver

Shen X, Zhu C, Liu X, Zheng H, Wu Q, Xie J, et al. Engineered bacteria for augmented in situ tumor vaccination. Biomaterials Science. 2023. doi:10.1039/d2bm01593e

BibTeX
@article{Shen2023,
  author = {Shen, Xinyuan and Zhu, Chaojie and Liu, Xutao and Zheng, Hanqi and Wu, Qing and Xie, Jijin and Huang, Hao and Liao, Ziyan and Shi, Jiaqi and Nan, Kewang and Wang, Junxia and Mao, Xuming and Gu, Zhen and Li, Hongjun},
  title = {Engineered bacteria for augmented in situ tumor vaccination},
  journal = {Biomaterials Science},
  year = {2023},
  doi = {10.1039/d2bm01593e}
}
Kostenlos starten →